Overview

Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.

Status:
Withdrawn
Trial end date:
2020-05-03
Target enrollment:
Participant gender:
Summary
Study to compare pharmacokinetics of tacrolimus prolonged-release (PR) capsules and Advagraf® PR capsules in stable kidney transplant patients.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Tacrolimus